Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Onconova Therapeutics Inc (NASDAQ:ONTX)

2.65
Delayed Data
As of Dec 08
 +0.10 / +3.92%
Today’s Change
2.11
Today|||52-Week Range
18.90
-72.30%
Year-to-Date
No recent news for Onconova Therapeutics Inc.

Today’s Trading

Previous close2.55
Today’s open2.49
Day’s range2.46 - 2.67
Volume25,849
Average volume (3 months)138,249
Market cap$17.9M
Dividend yield--
Data as of 12/08/2016

Growth & Valuation

Earnings growth (last year)+64.29%
Earnings growth (this year)+43.71%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,332.00%
P/E ratioNM
Price/Sales1.90
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
TNXPTonix Pharmaceutical...+0.05+11.22%
CBLICleveland Biolabs In...-0.00-0.09%
CYCCCyclacel Pharmaceuti...+0.06+1.48%
MRNSMarinus Pharmaceutic...-0.02-2.08%
Data as of 12/08/2016

Financials

Next reporting dateMarch 30, 2017
EPS forecast (this quarter)-$1.00
Annual revenue (last year)$11.5M
Annual profit (last year)-$24.0M
Net profit margin-209.31%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ramesh Kumar
Chief Financial &
Accounting Officer
Mark Guerin
Corporate headquarters
Newtown, Pennsylvania

Forecasts


Search for Jobs